ArticleBrain imaging and behavior2025
Causal association between plasma inflammatory proteins and longitudinal brain atrophy: a bidirectional Mendelian randomisation study.
Article in Brain imaging and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Systemic inflammation is closely associated with brain health. This study aimed to explore the causal association between plasma inflammatory proteins and longitudinal brain atrophy. Datasets were obtained from non-overlapping genome-wide association studies of 91 inflammation-related plasma proteins (N = 14,824), and 15 longitudinal changes in brain structure across patient lifespan (N = 15,640). Causal effects were estimated using inverse variance-weighted estimates. Sensitivity analyses were performed using the MR-Egger intercept test, Cochran's Q test, and the leave-one-out analysis. Bidirectional Mendelian Randomisation analysis using a Bonferroni-corrected significance threshold (p < 1.83 × 10⁻⁵) revealed no significant causal relationships between the 91 inflammatory proteins and 15 longitudinal brain structural phenotypes. However, nominal associations were identified (p < 0.05), including 14 putative positive and 25 negative associations in forward MR (proteins → brain) analyses, and 17 putative positive and 17 negative associations in reverse MR (brain → proteins) analyses. Nominal findings included elevated CCL20 levels associated with increased nucleus accumbens volume (β = 3.24, p = 0.0035); higher MMP-1 concentrations associated with accelerated cortical thinning (β = -2.49, p = 0.0091); reduced cortical thickness associated with decreased TSLP expression (β = 0.015, p = 0.0028); ventricular enlargement associated with reduced IL-15RA levels (β = -0.00034, p = 0.0067). Alterations in inflammation-related plasma proteins may contribute to longitudinal changes in brain volumes. Chronic brain structural changes appear reciprocally linked to systemic inflammatory profiles. These findings suggest potential bidirectional pathways between systemic inflammation and brain structural dynamics, providing new insights into brain-multi-organ interactions in neuroinflammatory processes.
Indexed as
Identifiers
41108338What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.